Assessment of antitumor activity rhizonin for human lung cancer cell lines: A potent new drug for drug-resistant lung cancer

N. Takigawa, T. Ohnoshi, H. Veoka, T. Horiguchi, K. Kiura, M. Tabata, Y. Segawa, T. Shibayama, K. Genba, T. Matsumura, M. Chikamori, S. Ikubo, K. Kawata, K. Matsuo, I. Kimura

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1221-1226
Number of pages6
JournalJapanese Journal of Cancer and Chemotherapy
Volume20
Issue number9
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Takigawa, N., Ohnoshi, T., Veoka, H., Horiguchi, T., Kiura, K., Tabata, M., Segawa, Y., Shibayama, T., Genba, K., Matsumura, T., Chikamori, M., Ikubo, S., Kawata, K., Matsuo, K., & Kimura, I. (1993). Assessment of antitumor activity rhizonin for human lung cancer cell lines: A potent new drug for drug-resistant lung cancer. Japanese Journal of Cancer and Chemotherapy, 20(9), 1221-1226.